Consistent with EMT’s role in cancer progression, Gal-1 has been implicated in facilitating EMT across various cancers, such as hepatocellular carcinoma and ovarian cancer, through activation of pathways like PI3K/AKT and MAPK JNK/p38 [39,40]. Here, MAPK8 is linked to hepatocellular carcinoma.